X. Zou

HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial–mesenchymal transition

Jin Gao, Yijiang Chen, Tianwei Xu, 2022, Medical Oncology.

Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis.

Chen-chen Wei, Niu Zhang, Tianwei Xu, 2023, Pharmacological research.

HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial–mesenchymal transition

Jin Gao, Yijiang Chen, Tianwei Xu, 2022, Medical Oncology.

Long noncoding RNA SNHG17: a novel molecule in human cancers

Jin Gao, Zhaoxia Wang, Chen-chen Wei, 2022, Cancer Cell International.

Long noncoding RNA SNHG15: A promising target in human cancers

Niu Zhang, Tianwei Xu, Zhaoxia Wang, 2023, Frontiers in Oncology.